Surrozen, Inc. Files 8-K for Material Agreement

Ticker: SRZNW · Form: 8-K · Filed: Oct 2, 2024 · CIK: 1824893

Surrozen, Inc./De 8-K Filing Summary
FieldDetail
CompanySurrozen, Inc./De (SRZNW)
Form Type8-K
Filed DateOct 2, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $2.3 million, $2.6 million, $400,000
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, filing, corporate-action

Related Tickers: SRZN

TL;DR

Surrozen (SRZN) filed an 8-K on Oct 2 for an Oct 1 material agreement.

AI Summary

Surrozen, Inc. filed an 8-K on October 2, 2024, reporting on events that occurred on October 1, 2024. The filing indicates the entry into a material definitive agreement and includes financial statements and exhibits. Surrozen, Inc. is a Delaware-incorporated company focused on biological products.

Why It Matters

This 8-K filing signals a significant development for Surrozen, Inc., potentially impacting its financial standing and future operations through a new material definitive agreement.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's financial health and stock performance.

Key Numbers

  • 001-39635 — SEC File Number (Identifies Surrozen's filings with the SEC)
  • 30-1374889 — IRS Employer Identification No. (Tax identification number for Surrozen)

Key Players & Entities

  • Surrozen, Inc. (company) — Registrant
  • October 01, 2024 (date) — Earliest event reported
  • October 02, 2024 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation
  • Consonance-HFW Acquisition Corp. (company) — Former company name

FAQ

What is the nature of the material definitive agreement entered into by Surrozen, Inc. on October 1, 2024?

The filing does not specify the details of the material definitive agreement, only that one was entered into on October 1, 2024.

When was Surrozen, Inc. incorporated?

Surrozen, Inc. was incorporated in Delaware.

What is Surrozen, Inc.'s former company name?

Surrozen, Inc.'s former company name was Consonance-HFW Acquisition Corp.

What is the primary business of Surrozen, Inc. according to the SIC code?

According to the Standard Industrial Classification (SIC) code, Surrozen, Inc. is in the business of Biological Products (No Diagnostic Substances).

What is the physical address of Surrozen, Inc.'s principal executive offices?

Surrozen, Inc.'s principal executive offices are located at 171 Oyster Point Blvd, Suite 400, South San Francisco, California, 94080.

Filing Stats: 622 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-10-02 16:28:02

Key Financial Figures

  • $0.0001 — nge on which registered Common Stock, $0.0001 par value per share SRZN The Nasdaq
  • $2.3 million — 29. The annual base rent escalates from $2.3 million for the first 12-month period to $2.6 m
  • $2.6 million — illion for the first 12-month period to $2.6 million for the final 12-month period. On or pr
  • $400,000 — e payment of a lease termination fee of $400,000 on or prior to December 31, 2025. The

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On October 1, 2024, Surrozen, Inc. (the "Company") through its wholly-owned subsidiary Surrozen Operating, Inc., entered into a lease amendment (the "Lease Amendment"), to its lease agreement with HCP Oyster Point III, LLC, dated August 4, 2016, as amended, for its headquarters in South San Francisco, California (the "Lease"). Pursuant to the Lease Amendment, the term of the Lease was extended by 48 months commencing on May 1, 2025 and expiring on April 30, 2029. The annual base rent escalates from $2.3 million for the first 12-month period to $2.6 million for the final 12-month period. On or prior to September 30, 2025, the Company has a one-time option to terminate the Lease by the payment of a lease termination fee of $400,000 on or prior to December 31, 2025. The foregoing description of the Lease Amendment is qualified in its entirety by the terms of the Lease Amendment, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein. The Lease is filed as Exhibit 10.20 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021 (file no. 001-39635) filed with the Securities and Exchange Commission on March 28, 2022.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 First Amendment to Lease, by and between Surrozen Operating, Inc. and HCP Oyster Point III LLC, dated October 1, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SURROZEN, INC. Date: October 2, 2024 By: /s/ Charles Williams Name: Charles Williams Title: Chief Financial Officer, Chief Operating Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.